Clinical Research Directory
Browse clinical research sites, groups, and studies.
An International Multicenter Clinical Study on Application of UroMed AI Doctor Based on Large Language Models
Sponsor: First Affiliated Hospital of Guangxi Medical University
Summary
This study evaluates our team's urology-specific AI (UroMed AI Doctor) for its safety, professionalism, knowledge and Q\&A ability, and tests its effectiveness against traditional manual urology care, to confirm if it can be a safe auxiliary tool and improve patients' preoperative experience. Before the study, we will test the AI with urology questions, compare it to international AI models (DeepSeek, ChatGPT, Google Gemini), and have two senior chief physicians evaluate it. In the clinical trial, patients at The First Affiliated Hospital of Guangxi Medical University will be randomly split into two groups: AI-assisted care or traditional care by a specialist. Two senior specialists will evaluate both groups blindly; each group will get preoperative education (AI or physician), with anxiety and satisfaction surveyed. Subsequently, a multi-center validation will be conducted with 11 domestic and international hospitals.
Official title: AN INTERNATIONAL MULTICENTER CLINICAL STUDY ON APPLICATION OF UROMED AI DOCTOR BASED ON LARGE LANGUAGE MODELS
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
1080
Start Date
2026-05-01
Completion Date
2029-07-31
Last Updated
2026-04-29
Healthy Volunteers
No
Interventions
UroMed AI Doctor-assisted Urological Diagnosis, Treatment and Preoperative Health Education
This urological intervention uses the independently developed UroMed AI Doctor, a urology-specialized large language model system distinct from generic medical AI tools. Trained \*\*exclusively\*\* on the latest international urology guidelines and high-quality literature, it has a built-in data cleaning system blocking non-standard knowledge sources, eliminating factual deviations and guideline misalignment common in general LLMs. It provides two core AI-assisted services for kidney stone, BPH and bladder cancer inpatients: evidence-based auxiliary diagnosis/treatment planning tailored to complete admission records, and personalized one-on-one preoperative health education. Uniquely equipped with ASEAN multilingual interaction and lightweight edge deployment for cross-border use, all AI outputs strictly adhere to urological clinical norms, ensuring professional accuracy and safety unavailable in non-specialized medical AI interventions.
Physician-led Urological Diagnosis, Treatment & Preoperative Education
This intervention consists of standard, physician-led urological care without any artificial intelligence support. Qualified urologists independently diagnose and create personalized treatment plans for inpatients with kidney stones, BPH, or bladder cancer, following official clinical guidelines and consensus. One-on-one preoperative education, including disease information, treatment procedures, and postoperative care, is provided directly by attending physicians. This arm represents routine clinical practice, serving as a clear, active comparator to the AI-assisted intervention, ensuring a direct, valid comparison in effectiveness and safety between traditional care and AI-supported care.
Locations (5)
The First Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, China
Binh Duong General Hospital
Thu Dau Mot, Binh Duong Province, Vietnam
Viet Duc University Hospital
Hanoi, Hanoi, Vietnam
Faculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City
Ho Chi Minh City, Ho Chi Minh City (Municipality), Vietnam
Hue Central Hospital
Huế, Thừa Thiên Huế Province, Vietnam